FR7116M - - Google Patents

Info

Publication number
FR7116M
FR7116M FR135175A FR135175A FR7116M FR 7116 M FR7116 M FR 7116M FR 135175 A FR135175 A FR 135175A FR 135175 A FR135175 A FR 135175A FR 7116 M FR7116 M FR 7116M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR135175A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR135175A priority Critical patent/FR7116M/fr
Priority to GB83869A priority patent/GB1187946A/en
Priority to CH10669A priority patent/CH501600A/en
Priority to BR20538569A priority patent/BR6905385D0/en
Priority to ES362231A priority patent/ES362231A1/en
Priority to DE1900772A priority patent/DE1900772C3/en
Application granted granted Critical
Publication of FR7116M publication Critical patent/FR7116M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C07C279/26—X and Y being nitrogen atoms, i.e. biguanides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
FR135175A 1968-01-08 1968-01-08 Expired FR7116M (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR135175A FR7116M (en) 1968-01-08 1968-01-08
GB83869A GB1187946A (en) 1968-01-08 1969-01-06 Dimethylbiguanide Derivative
CH10669A CH501600A (en) 1968-01-08 1969-01-07 Process for the preparation of a derivative of dimethyl biguanide
BR20538569A BR6905385D0 (en) 1968-01-08 1969-01-07 PROCESS OF PREPARING A NEW DIMETHY BIGUANIDE DERIVATIVE
ES362231A ES362231A1 (en) 1968-01-08 1969-01-08 Dimethylbiguanide Derivative
DE1900772A DE1900772C3 (en) 1968-01-08 1969-01-08 Salt of N, N-dimethylbiguanide and p-chlorophenoxyacetic acid and medicinal products containing this

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR135175A FR7116M (en) 1968-01-08 1968-01-08

Publications (1)

Publication Number Publication Date
FR7116M true FR7116M (en) 1969-07-15

Family

ID=8644240

Family Applications (1)

Application Number Title Priority Date Filing Date
FR135175A Expired FR7116M (en) 1968-01-08 1968-01-08

Country Status (6)

Country Link
BR (1) BR6905385D0 (en)
CH (1) CH501600A (en)
DE (1) DE1900772C3 (en)
ES (1) ES362231A1 (en)
FR (1) FR7116M (en)
GB (1) GB1187946A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2275199A1 (en) * 1974-06-19 1976-01-16 Cerpha Dimethylbiguanide (4-chlorophenoxy)-isobutyrate - for use as a hypolipaemic agent
US4835184A (en) * 1985-07-31 1989-05-30 Albert Rolland Sa Novel pharmaceutical compositions intended to the treatment of neuropathies and promoting the nervous regeneration
FR2796551A1 (en) * 1999-07-23 2001-01-26 Lipha New metformin salts, e.g. the thioctate, hippurate or alginate, having improved passage through the digestive barrier and improved resorption, useful for treating diabetes
FR2796940A1 (en) * 1999-07-26 2001-02-02 Lipha Metformin salts active in alleviating diabetic metabolic syndromes, such as protein metabolic disorders, hypertension, inflamed joints, obesity and increase in serum triglycerides

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2264525B1 (en) * 1974-03-22 1977-11-04 Expl Marques Brevets Et
US4080472A (en) * 1974-03-22 1978-03-21 Societe D'etudes Et D'exploitation De Marques Et Brevets S.E.M.S. Metformin 2-(p-chlorophenoxy)-2-methylpropionate

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2275199A1 (en) * 1974-06-19 1976-01-16 Cerpha Dimethylbiguanide (4-chlorophenoxy)-isobutyrate - for use as a hypolipaemic agent
US4835184A (en) * 1985-07-31 1989-05-30 Albert Rolland Sa Novel pharmaceutical compositions intended to the treatment of neuropathies and promoting the nervous regeneration
FR2796551A1 (en) * 1999-07-23 2001-01-26 Lipha New metformin salts, e.g. the thioctate, hippurate or alginate, having improved passage through the digestive barrier and improved resorption, useful for treating diabetes
FR2796940A1 (en) * 1999-07-26 2001-02-02 Lipha Metformin salts active in alleviating diabetic metabolic syndromes, such as protein metabolic disorders, hypertension, inflamed joints, obesity and increase in serum triglycerides

Also Published As

Publication number Publication date
BR6905385D0 (en) 1973-02-08
GB1187946A (en) 1970-04-15
DE1900772B2 (en) 1979-06-07
DE1900772C3 (en) 1980-01-31
ES362231A1 (en) 1970-12-01
DE1900772A1 (en) 1969-10-09
CH501600A (en) 1971-01-15

Similar Documents

Publication Publication Date Title
AU1946070A (en)
AU428130B2 (en)
AU5184069A (en)
AU6168869A (en)
AU6171569A (en)
AU429879B2 (en)
AU416157B2 (en)
AU4811568A (en)
AU421558B1 (en)
AU3789668A (en)
AR203075Q (en)
AU4744468A (en)
BE726474A (en)
AU5758767A (en)
BE727779A (en)
BE727682A (en)
BE727592A (en)
BE727171A (en)
BE727164A (en)
BE727151A (en)
BE726867A (en)
BE726687A (en)
BE728040A (en)
BE725607A (en)
BE709319A (en)

Legal Events

Date Code Title Description
TP Transmission of property